• We know how to improve serology testing performance

    Solutions for the precise detection of SARS-CoV-2 antibody natural response and immunity after vaccination. 

    Learn more

  • SARS-CoV-2 Serology Testing by Flow Cytometry

    Watch our webinar again

    Go to webinar

  • SARS-CoV-2 Multiantigen IgG + IgA + IgM Assay

    COVID-19  Multiplex Bead-Based Immunoassay simultaneously targeting four separate SARS-Cov-2 specific antigens and 3 immunoglobulins.

    More about the assay

  • Anti-SARS-Cov-2 ELISA Spike IgG | IgA Kits

    Designed to monitor SARS-CoV-2 immune response, detecting antibodies generated as a response to SARS-CoV-2 natural infection and vaccination.

    See more

  • SARS-COV-2 ELISA Mpro IgG | IgA Kits

    Highly sensitive and accurate test screening patients whose immune system has reacted to the virus as a result of natural infection.

    View Assay

  • Developed and Manufactured in Spain

    Guaranteed Supply. Patented under Spanish National Research Council (CSIC) licence.

    Learn more

    Download our COVID-19 Catalog!

    I have read the terms and conditions of the Privacy Policy and accept the terms.

    Innovating to deliver
    high-quality reliable testing technology.

    At IMMUNOSTEP we  develop innovative solutions in order to help improving  research and diagnosis performance in key areas of development.

    We will continue to work every day to deliver high-quality technology in order to fight against the global health emergency by assuring reliable results.

    Leading-edge research solutions to increase the analysis potential.

    Extensive Research, Development and Innovation (R&D&i) programme.

    Seeking efficiency and offering alternatives to traditional solutions.

    Successful technology licensing and meaningful worldwide collaborations.

    Our Commitment:
    Reliability and Innovation

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new virus that belongs to the family of coronaviruses, of the genus Betacoronavirus, which emerged in China in the city of Wuhan, Hubei province in December 2019 and was It has spread throughout the world until being declared by WHO as a pandemic in March 2020.

    In response to the Covid-19 pandemic, CSIC research groups have worked in collaboration with Immunostep to develop these serological tests capable of detecting specific SARS-CoV-2  antibodies  and monitoring immune responses with an estimated accuracy close to 100%.

    PRODUCTS

    Reliability

    Detecting SARS-CoV-2 immune response with an  accuracy close to 100%.

    INNOVATION

    High sensitivity and specifity targeting highly antigenic structural and  non-structural proteins.

    EFFICIENCY

    Very early antibody detection from the symptoms onset identifying IgG, IgA and IgM immunoglobulins.

    RESEARCH AND DEVELOPMENT 

    We work everyday to improve serology testing performance by innovating and adapting new technology to collaborate building meaningful clinical investigation. 

     

    More about the assay

    CE/IVD kits are only suitable for clinical use in European Union and countries with EU conformity recognition agreements. Manufactured in Spain by Immunostep under CSIC Patent License.

    Follow us on our networks and stay informed.

    LOCATION:

    Centro Investigación del Cáncer (C.I.C) Avda. Universidad de Coimbra, s/n Campus Miguel de Unamuno 37007 Salamanca

    +34 923 294 827 

    info@immunostep.com

    © 2021 Immunostep

    Website created & maintained by Especialistas Web